Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Phase Ib, single centre, double-blind, double-dummy placebo-controlled, randomised, stepwise dose escalated, vaccine trial to assess the safety and immunogenicity of the candidate ChAdOx1 Chik and ChAdOx1 Zika vaccines, given as a standalone vaccines or in co-administration. Healthy volunteers aged 18-50 years old, residents of the metropolitan area of Monterrey (Mexico), will be recruited as participants
Epistemonikos ID: efd9434363a70ebfa7a508e5bcc4ce1793a6eb09
First added on: May 07, 2024